Contact us
Need more information?
Our dedicated team of Novartis representitives based throught the UK are on hand to answer your local query.
What are you looking for?
top
Image
Image
Resources
This page/content is for Great Britain healthcare professionals only. If you require information for Northern Ireland please refer to the Northern Ireland electronic medicines compendium (emc).
Aimovig is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.1
You can download certain files below. In order to do this, you will be required to register.
Please do not share links to this website or screenshots with patients, as this website is intended for healthcare professionals only.
Image
Your guide to Aimovig
PDF
Your guide to Aimovig®
A guide for patients prescribed Aimovig to provide them with important information about what Aimovig is, who it is for, how it works and what to expect during treatment.
Reference
Aimovig® (erenumab) Summary of Product Characteristics.
UK | October 2024 | FA-11214820
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
